Astellas Pharma Inc. buy melinda
Start price
26.03.18
/
50%
€12.63
Target price
05.04.18
€12.98
Performance (%)
4.02%
End price
05.04.18
€12.99
Summary
This prediction ended on 05.04.18 with a price of €12.99. The BUY prediction by melinda finished with a performance of 4.02%. melinda has a follow-up prediction for Astellas Pharma Inc. where he still thinks Astellas Pharma Inc. is a Buy. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Astellas Pharma Inc. | 1.577% | 1.577% | -30.087% | -35.260% |
iShares Core DAX® | 0.786% | -0.427% | 17.458% | 17.620% |
iShares Nasdaq 100 | 2.297% | 7.331% | 38.189% | 53.439% |
iShares Nikkei 225® | 3.076% | 3.279% | 13.174% | 10.191% |
iShares S&P 500 | 0.902% | 3.970% | 29.787% | 46.282% |
Comments by melinda for this prediction
In the thread Astellas Pharma Inc. diskutieren
SectorDrug Pharmaceuticals Agenda 28/03 Endgültige Dividende Detachment
Astellas Pharma Inc. und Seattle Genetics, Inc. (SGEN) haben bekannt gegeben, dass die US-amerikanische Gesundheitsbehörde Breakthrough Therapy für ein Antikörper-Wirkstoff-Konjugat, Vedotin-Konjugat, Patienten mit lokal fortgeschrittenem oder metastasierendem Urothelkarzinom, die zuvor behandelt wurden, gewährt hat Checkpoint-Inhibitoren.
(Zielkurs erreicht)
Current prediction by melinda for Astellas Pharma Inc.
Astellas Pharma Inc.
Start price
Target price
Perf. (%)
€13.42
25.07.23
25.07.23
€16.00
25.07.24
25.07.24
-30.87%
08.07.24
08.07.24
Stopped prediction by melinda for Astellas Pharma Inc.
Astellas Pharma Inc.
Start price
Target price
Perf. (%)
€45.42
17.11.13
17.11.13
€42.00
19.05.14
19.05.14
-81.45%
19.05.14
19.05.14
Astellas Pharma Inc.
Start price
Target price
Perf. (%)
€26.00
10.08.10
10.08.10
€33.00
10.02.11
10.02.11
12.27%
10.02.11
10.02.11